Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 7b.

Time to steroid dependence: During the treatment period

Group No. of Patients No. of Patients with Frequent Relapses No. of Patients with Steroid Resistance as Competing Event No. of Patients Censored Median (95% CI) (days) Hazard Ratio (95% CI)
MMF 39 6 0 33 not reached 0.22 (0.09 to 0.53)
Placebo 39 20 0 19 506.0 (360.0 to not reached)